Physician profile
Armin Kiankhooy
NPI 1225156482
$940,569.92
in general payments reported to CMS, 2019-2025
12 companies · $61K in 2025
The $61K reported for 2025 was more than what 98% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $25K · 2021: $132K · 2022: $233K · 2023: $226K · 2024: $197K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $450K · Travel and Lodging: $24K · Food and Beverage: $9,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $450,000.00 |
| Travel and Lodging | $23,906.22 |
| Food and Beverage | $9,509.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $936,780.28 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,851.78 | 2021-2024 | Micra |
| Abbott Laboratories | $674.37 | 2019-2024 | Aveir |
| Edwards Lifesciences Corporation | $598.98 | 2021-2025 | Konect Resilia, Sapien 3 Ultra Resilia |
| Abiomed | $288.94 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $116.20 | 2019 | |
| Bardy Diagnostics, INC. | $78.38 | 2021-2022 | |
| Kls-Martin L.P. | $66.03 | 2020-2022 | |
| Ethicon US, LLC | $56.68 | 2022-2023 | Surgicel Nu-Knit |
| Angiodynamics, INC. | $21.38 | 2020 | |
| Tactile Systems Technology INC | $19.34 | 2022 | |
| Smith+Nephew, INC. | $17.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armin Kiankhooy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.